Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells-Reference-Cited by-同舟云学术

Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells

Published:2023-07-25 Issue:15 Volume:17 Page:14852-14870
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Zhang Chenshuang¹,Teng Yilong¹,Li Fengqiao,Ho William,Bai Xin¹,Xu Xiaoyang^ORCID,Zhang Xue-Qing¹^ORCID

Affiliation:

1. Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmacy, National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China

Funder

Natural Science Foundation of Shanghai

Shanghai Jiao Tong University

Division of Chemical, Bioengineering, Environmental, and Transport Systems

Gustavus and Louise Pfeiffer Research Foundation

National Center of Technology Innovation for Biopharmaceuticals

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c03217

Reference63 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

3. World Gastroenterology Organisation Global Guidelines

4. Pathology of non-alcoholic fatty liver disease

5. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis;Beilstein Journal of Nanotechnology;2024-08-23

2. RNAs in the diagnosis and treatment of major diseases;Chinese Science Bulletin;2024-08-01

3. Smart Microneedle Arrays Integrating Cell‐Free Therapy and Nanocatalysis to Treat Liver Fibrosis;Advanced Science;2024-06-14

4. Farnesoid X receptor modulator 12β-( m -methyl-benzoyl)-11,12-dihydro oleanolic acid represses liver fibrosis by inhibiting ERK/p38 signaling pathways;Toxicology Mechanisms and Methods;2024-05-14

5. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities;Drug Delivery and Translational Research;2024-03-06